These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9560456)
1. Tyrosine kinase inhibitors suppress N-type and T-type Ca2+ channel currents in NG108-15 cells. Morikawa H; Fukuda K; Mima H; Shoda T; Kato S; Mori K Pflugers Arch; 1998 Jun; 436(1):127-32. PubMed ID: 9560456 [TBL] [Abstract][Full Text] [Related]
2. Protein-tyrosine kinases activate while protein-tyrosine phosphatases inhibit L-type calcium channel activity in pituitary GH3 cells. Cataldi M; Taglialatela M; Guerriero S; Amoroso S; Lombardi G; di Renzo G; Annunziato L J Biol Chem; 1996 Apr; 271(16):9441-6. PubMed ID: 8621613 [TBL] [Abstract][Full Text] [Related]
3. Specific inhibition of stretch-induced increase in L-type calcium channel currents by herbimycin A in canine basilar arterial myocytes. Kimura M; Obara K; Sasase T; Ishikawa T; Tanabe Y; Nakayama K Br J Pharmacol; 2000 Jun; 130(4):923-31. PubMed ID: 10864901 [TBL] [Abstract][Full Text] [Related]
4. Altered regulation of L-type channels by protein kinase C and protein tyrosine kinases as a pathophysiologic effect in retinal degeneration. Mergler S; Steinhausen K; Wiederholt M; Strauss O FASEB J; 1998 Sep; 12(12):1125-34. PubMed ID: 9737715 [TBL] [Abstract][Full Text] [Related]
5. Modulation of a cloned human A-type voltage-gated potassium channel (hKv1.4) by the protein tyrosine kinase inhibitor genistein. Zhang ZH; Wang Q Pflugers Arch; 2000 Sep; 440(5):784-92. PubMed ID: 11007322 [TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine kinase inhibitors reduce high-voltage activating calcium currents in CA1 pyramidal neurones from rat hippocampal slices. Potier B; Rovira C Brain Res; 1999 Jan; 816(2):587-97. PubMed ID: 9878884 [TBL] [Abstract][Full Text] [Related]
7. Evidence for a role of protein tyrosine kinases in cell death induced by gp120 in CHP100 neuroblastoma cells. Russo R; Navarra M; Rotiroti D; Di Renzo G Toxicol Lett; 2003 Apr; 139(2-3):207-11. PubMed ID: 12628756 [TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinases modulate the activity of single L-type calcium channels in vascular smooth muscle cells from rat portal vein. Liu H; Sperelakis N Can J Physiol Pharmacol; 1997 Sep; 75(9):1063-8. PubMed ID: 9365814 [TBL] [Abstract][Full Text] [Related]
9. The protein tyrosine kinase inhibitor herbimycin A, but not genistein, specifically inhibits signal transduction by the T cell antigen receptor. Graber M; June CH; Samelson LE; Weiss A Int Immunol; 1992 Nov; 4(11):1201-10. PubMed ID: 1472473 [TBL] [Abstract][Full Text] [Related]
10. Tyrosine kinase inhibitor, genistein, inhibits macroscopic L-type calcium current in rat portal vein smooth muscle cells. Liu H; Li K; Sperelakis N Can J Physiol Pharmacol; 1997 Sep; 75(9):1058-62. PubMed ID: 9365813 [TBL] [Abstract][Full Text] [Related]
12. Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets. Jonas JC; Plant TD; Gilon P; Detimary P; Nenquin M; Henquin JC Br J Pharmacol; 1995 Feb; 114(4):872-80. PubMed ID: 7773549 [TBL] [Abstract][Full Text] [Related]
13. Coupling of the cloned mu-opioid receptor with the omega-conotoxin-sensitive Ca2+ current in NG108-15 cells. Morikawa H; Fukuda K; Kato S; Mori K; Higashida H J Neurochem; 1995 Sep; 65(3):1403-6. PubMed ID: 7643119 [TBL] [Abstract][Full Text] [Related]
14. Opioid potentiation of N-type Ca2+ channel currents via pertussis-toxin-sensitive G proteins in NG108-15 cells. Morikawa H; Mima H; Uga H; Shoda T; Fukuda K Pflugers Arch; 1999 Aug; 438(3):423-6. PubMed ID: 10398877 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of genistein on ATP-sensitive K+ channels in rabbit portal vein smooth muscle. Ogata R; Kitamura K; Ito Y; Nakano H Br J Pharmacol; 1997 Dec; 122(7):1395-404. PubMed ID: 9421287 [TBL] [Abstract][Full Text] [Related]
16. Role of tyrosine phosphorylation in potassium channel activation. Functional association with prolactin receptor and JAK2 tyrosine kinase. Prevarskaya NB; Skryma RN; Vacher P; Daniel N; Djiane J; Dufy B J Biol Chem; 1995 Oct; 270(41):24292-9. PubMed ID: 7592639 [TBL] [Abstract][Full Text] [Related]
17. Separation of calcium channel current components in mouse chromaffin cells superfused with low- and high-barium solutions. Hernández-Guijo JM; de Pascual R; García AG; Gandía L Pflugers Arch; 1998 Jun; 436(1):75-82. PubMed ID: 9560449 [TBL] [Abstract][Full Text] [Related]
18. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. Blair HC; Jordan SE; Peterson TG; Barnes S J Cell Biochem; 1996 Jun; 61(4):629-37. PubMed ID: 8806087 [TBL] [Abstract][Full Text] [Related]
19. Astrocyte stellation induced by tyrosine kinase inhibitors in culture. Abe K; Saito H Brain Res; 1999 Aug; 837(1-2):306-8. PubMed ID: 10434017 [TBL] [Abstract][Full Text] [Related]
20. Re-evaluation of the P/Q Ca2+ channel components of Ba2+ currents in bovine chromaffin cells superfused with solutions containing low and high Ba2+ concentrations. Albillos A; García AG; Olivera B; Gandía L Pflugers Arch; 1996 Oct; 432(6):1030-8. PubMed ID: 8781197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]